Literature DB >> 12459079

[The mitochondrial organelle and the heart].

José Marín-García1, Michael J Goldenthal.   

Abstract

The heart is highly dependent for its function on oxidative energy generated in mitochondria, primarily by fatty acid beta-oxidation, respiratory electron chain and oxidative phosphorylation. Defects in mitochondrial structure and function have been found in association with cardiovascular diseases such as dilated and hypertrophy cardiomyopathy, cardiac conduction defects and sudden death, ischemic and alcoholic cardiomyopathy, as well as myocarditis. While a subset of these mitochondrial abnormalities have a defined genetic basis (e.g. mitochondrial DNA changes leading to oxidative phosphorylation dysfunction,fatty acid beta-oxidation defects due to specific nuclear DNA mutations), other abnormalities appear to be due to a more sporadic or environmental cardiotoxic insult or have not yet been characterized.This review focuses on abnormalities in mitochondrial bioenergetic function and mitochondrial DNA defects associated with cardiovascular diseases, their significance in cardiac pathogenesis as well as on the available diagnostic and therapeutic options. A concise background concerning mitochondrial biogenesis and bioenergetic pathways during cardiac growth,development and aging will also be provided.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459079     DOI: 10.1016/s0300-8932(02)76802-4

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  8 in total

1.  A delta-sarcoglycan gene polymorphism as a risk factor for hypertrophic cardiomyopathy.

Authors:  Rosa M Ordoñez-Razo; Martín H Garrido-Garduño; Ramón A Pérez-Martínez; Victor M Ruiz; Esteban Herrera-Tepatlán; Maricela Rodríguez-Cruz; Ana L Jiménez-Vaca; Fernando Minauro-Sanmiguel; Fabio A Salamanca-Gómez
Journal:  Genet Test Mol Biomarkers       Date:  2012-04-23

2.  Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning.

Authors:  Mourad Ogbi; John A Johnson
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Divergent mitochondrial biogenesis responses in human cardiomyopathy.

Authors:  Preeti Ahuja; Jonathan Wanagat; Zhihua Wang; Yibin Wang; David A Liem; Peipei Ping; Igor A Antoshechkin; Kenneth B Margulies; W Robb Maclellan
Journal:  Circulation       Date:  2013-04-15       Impact factor: 29.690

4.  Mitochondrial 8-oxoguanine glycosylase decreases mitochondrial fragmentation and improves mitochondrial function in H9C2 cells under oxidative stress conditions.

Authors:  Moises Torres-Gonzalez; Thomas Gawlowski; Heidi Kocalis; Brian T Scott; Wolfgang H Dillmann
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-04       Impact factor: 4.249

5.  Quercetin Affects Erythropoiesis and Heart Mitochondrial Function in Mice.

Authors:  Lina M Ruiz; Celia Salazar; Erik Jensen; Paula A Ruiz; William Tiznado; Rodrigo A Quintanilla; Marlen Barreto; Alvaro A Elorza
Journal:  Oxid Med Cell Longev       Date:  2015-05-28       Impact factor: 6.543

Review 6.  Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine.

Authors:  Jie Wang; Fei Lin; Li-Li Guo; Xing-Jiang Xiong; Xun Fan
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-17       Impact factor: 2.629

Review 7.  Antioxidants Protect against Arsenic Induced Mitochondrial Cardio-Toxicity.

Authors:  Clare Pace; Ruben Dagda; Jeff Angermann
Journal:  Toxics       Date:  2017-12-05

8.  Correlation between functional and ultrastructural substrate in Brugada syndrome.

Authors:  Pablo E Tauber; Virginia Mansilla; Guillermo Mercau; Felix Albano; Ricardo R Corbalán; Sara S Sánchez; Stella M Honoré
Journal:  HeartRhythm Case Rep       Date:  2016-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.